FDG PET for evaluating breast cancer.
D054598:Blue Cross Blue Shield Insurance Plans; D001943:Breast Neoplasms / Q000175:diagnosis*; D018795:Device Approval; D017277:Drug Approval; D019317:Evidence-Based Medicine; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D019275:Radiopharmaceuticals; D012008:Recurrence; D012680:Sensitivity and Specificity; D013673:Technology Assessment, Biomedical; D014055:Tomography, Emission-Computed; D014481:United States; D014486:United States Food and Drug Administration
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18